These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36875066)

  • 1. Interleukin-32 as a biomarker in rheumatic diseases: A narrative review.
    Kwon OC; Park MC; Kim YG
    Front Immunol; 2023; 14():1140373. PubMed ID: 36875066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases.
    Azizi G; Simhag A; El Rouby NM; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):246-54. PubMed ID: 26546892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the pathogenic role of IL-6 in rheumatic diseases.
    Kaneko Y; Takeuchi T
    Cytokine; 2021 Oct; 146():155645. PubMed ID: 34303949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population.
    Golds EE; Stephen IB; Esdaile JM; Strawczynski H; Poole AR
    Cell Immunol; 1983 Nov; 82(1):196-209. PubMed ID: 6640674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
    Rafael-Vidal C; Pérez N; Altabás I; Garcia S; Pego-Reigosa JM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis and rheumatic diseases.
    Maruotti N; Corrado A; Cantatore FP
    Reumatismo; 2014 Jun; 66(2):125-35. PubMed ID: 25069494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune rheumatic diseases associated with granulomatous mastitis.
    Parperis K; Achilleos S; Costi E; Vardas M
    Rheumatol Int; 2023 Mar; 43(3):399-407. PubMed ID: 36418558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular Manifestations in Rheumatoid Arthritis, Connective Tissue Disease, and Vasculitis: A Systematic Review and Metaanalysis.
    Turk MA; Hayworth JL; Nevskaya T; Pope JE
    J Rheumatol; 2021 Jan; 48(1):25-34. PubMed ID: 32358156
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Iwaszko M; Wielińska J; Świerkot J; Kolossa K; Sokolik R; Bugaj B; Chaszczewska-Markowska M; Jeka S; Bogunia-Kubik K
    Front Immunol; 2021; 12():631603. PubMed ID: 34177886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
    Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases.
    da Rocha Junior LF; Branco Pinto Duarte AL; de Melo Rêgo MJB; de Almeida AR; de Melo Vilar K; de Lima HD; Tavares Dantas A; de Ataíde Mariz H; da Rocha Pitta I; da Rocha Pitta MG
    Immunol Lett; 2020 Apr; 220():38-43. PubMed ID: 31954799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.
    Crowson CS; Matteson EL; Myasoedova E; Michet CJ; Ernste FC; Warrington KJ; Davis JM; Hunder GG; Therneau TM; Gabriel SE
    Arthritis Rheum; 2011 Mar; 63(3):633-9. PubMed ID: 21360492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune system and rheumatic diseases in the elderly].
    Schirmer M
    Dtsch Med Wochenschr; 2016 Jun; 141(11):794-6. PubMed ID: 27254630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version].
    Albrecht K; Binder S; Minden K; Poddubnyy D; Regierer AC; Strangfeld A; Callhoff J
    Z Rheumatol; 2023 Nov; 82(9):727-738. PubMed ID: 36592211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatic diseases and Klinefelter's syndrome.
    Rovenský J; Imrich R; Lazúrová I; Payer J
    Ann N Y Acad Sci; 2010 Apr; 1193():1-9. PubMed ID: 20398000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel interleukin-1 cytokine family members in inflammatory diseases.
    Hahn M; Frey S; Hueber AJ
    Curr Opin Rheumatol; 2017 Mar; 29(2):208-213. PubMed ID: 27926540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
    Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
    Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and promise of targeting miRNA in rheumatic diseases: a computational approach to identify miRNA association with cell types, cytokines, and disease mechanisms.
    Shaikh FS; Siegel RJ; Srivastava A; Fox DA; Ahmed S
    Front Immunol; 2023; 14():1322806. PubMed ID: 38264662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular manifestations of rheumatic diseases.
    Kemeny-Beke A; Szodoray P
    Int Ophthalmol; 2020 Feb; 40(2):503-510. PubMed ID: 31583550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-35: a new immunomodulator in autoimmune rheumatic diseases.
    Sakkas LI; Mavropoulos A; Perricone C; Bogdanos DP
    Immunol Res; 2018 Jun; 66(3):305-312. PubMed ID: 29749583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.